![]() Pulmatrix Pulmatrix develops inhaled therapies for the treatment, prevention, and transmission of infectious and progressive respiratory diseases. | ||
Founding Date | Founding Date 2003 | Founding Date 1929 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Lexington, US HQ | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more |
Employees | Employees 228% decrease | Employees 5,358 |
Valuation ($) | Valuation ($) 8 m | Valuation ($) 10.2 b |
Financial | ||
Net income | Net income ($5.2m) (FY, 2025) | Net income €445.1m (FY, 2025) |